EIF3D and cancer: According to recent research,eIF3d is overexpressed in a number of cancerous tumors,such as melanoma,3 prostate cancer,4 and colon cancer.5 In a number of cancer types, eIF3d has also been identifiedas a possible therapeutic target.2,3,6 Recent data suggest that dysregulated eIF3d expression plays a significant role in cancer and various geneticdisorders, highlighting the urgent need for innovative detection strategies.This underscores the growing demand for advances in cancer biomarkerscreening and detection.